TIE2 Anti-TIE2 antibody and Use Thereof

The present invention relates to an antibody, which specifically binds to tyrosine-protein kinase receptor TIE-2 (TIE2) so as to possess functions of blood vessel normalization and stabilization through receptor phosphorylation. More particularly, the present invention relates to: an anti-TIE2 antib...

Full description

Saved in:
Bibliographic Details
Main Authors PARK CHEONHO, YOO JIN SAN, PARK BEOM YONG, LEE WEON SUP, LEE EUN AH, KANG NU RI, LEE YOUNGAE, KIM DO YUN
Format Patent
LanguageEnglish
Korean
Published 24.02.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to an antibody, which specifically binds to tyrosine-protein kinase receptor TIE-2 (TIE2) so as to possess functions of blood vessel normalization and stabilization through receptor phosphorylation. More particularly, the present invention relates to: an anti-TIE2 antibody; a nucleic acid encoding the same; a vector comprising the nucleic acid; a cell transformed with the vector; a method for preparing the antibody; an agent for stabilizing blood vessels and a composition for treating angiogenesis-associated diseases, both of which comprise the antibody; and a composition for co-administration with a pharmaceutical composition for tumor or cancer treatment and with a composition other than an antibody binding to TIE2. 본 발명은 TIE2 (Tyrosine-protein kinase receptor TIE-2)에 특이적으로 결합하여 수용체의 인산화를 통해 혈관을 정상화(vessel normalization)하고, 안정화 (stabilization)시키는 기능을 보유한 항체와 관련된 것으로, 항-TIE2 항체, 이를 코딩하는 핵산, 상기 핵산을 포함하는 벡터, 상기 벡터로 형질전환된 세포, 상기 항체의 제조방법, 이를 포함하는 혈관안정화제 및 신생혈관형성(angiogenesis)과 관련된 질병의 치료용 조성물, 종양 또는 암 치료용 약학적 조성물 및 TIE2에 결합하는 항체 이외의 조성물과의 병용투여용 조성물에 관한 것이다.
AbstractList The present invention relates to an antibody, which specifically binds to tyrosine-protein kinase receptor TIE-2 (TIE2) so as to possess functions of blood vessel normalization and stabilization through receptor phosphorylation. More particularly, the present invention relates to: an anti-TIE2 antibody; a nucleic acid encoding the same; a vector comprising the nucleic acid; a cell transformed with the vector; a method for preparing the antibody; an agent for stabilizing blood vessels and a composition for treating angiogenesis-associated diseases, both of which comprise the antibody; and a composition for co-administration with a pharmaceutical composition for tumor or cancer treatment and with a composition other than an antibody binding to TIE2. 본 발명은 TIE2 (Tyrosine-protein kinase receptor TIE-2)에 특이적으로 결합하여 수용체의 인산화를 통해 혈관을 정상화(vessel normalization)하고, 안정화 (stabilization)시키는 기능을 보유한 항체와 관련된 것으로, 항-TIE2 항체, 이를 코딩하는 핵산, 상기 핵산을 포함하는 벡터, 상기 벡터로 형질전환된 세포, 상기 항체의 제조방법, 이를 포함하는 혈관안정화제 및 신생혈관형성(angiogenesis)과 관련된 질병의 치료용 조성물, 종양 또는 암 치료용 약학적 조성물 및 TIE2에 결합하는 항체 이외의 조성물과의 병용투여용 조성물에 관한 것이다.
Author YOO JIN SAN
KIM DO YUN
PARK BEOM YONG
LEE EUN AH
LEE WEON SUP
KANG NU RI
LEE YOUNGAE
PARK CHEONHO
Author_xml – fullname: PARK CHEONHO
– fullname: YOO JIN SAN
– fullname: PARK BEOM YONG
– fullname: LEE WEON SUP
– fullname: LEE EUN AH
– fullname: KANG NU RI
– fullname: LEE YOUNGAE
– fullname: KIM DO YUN
BookMark eNrjYmDJy89L5WRQD_F0NVJwzCvJ1AWzEoGspPyUSiAjRSG0OFUhJCO1KDU_jYeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxHsHGRkYGRoYGBlYGFs6GhOnCgBPuyim
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
DocumentTitleAlternate 항-TIE2 항체 및 이의 용도
ExternalDocumentID KR20210020839A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20210020839A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:46:06 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20210020839A3
Notes Application Number: KR20200102688
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210224&DB=EPODOC&CC=KR&NR=20210020839A
ParticipantIDs epo_espacenet_KR20210020839A
PublicationCentury 2000
PublicationDate 20210224
PublicationDateYYYYMMDD 2021-02-24
PublicationDate_xml – month: 02
  year: 2021
  text: 20210224
  day: 24
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies PHARMABCINE INC
RelatedCompanies_xml – name: PHARMABCINE INC
Score 3.2796688
Snippet The present invention relates to an antibody, which specifically binds to tyrosine-protein kinase receptor TIE-2 (TIE2) so as to possess functions of blood...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Title TIE2 Anti-TIE2 antibody and Use Thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210224&DB=EPODOC&locale=&CC=KR&NR=20210020839A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU8BtjqMzJJ0gfKJuibGaam6SabmabppBkkpyaBUYGQJ2u_s62fmEWriFWEawcSQA9sLAz4ntBx8OCIwRyUD83sJuLwuQAxiuYDXVhbrJ2UChfLt3UJsXdSgvWNw_8VEzcXJ1jXA38XfWc3Z2dY7SM0vCCIHupDS2NKRmYEV1JAGnbTvGuYE2pdSgFypuAkysAUAzcsrEWJgys4XZuB0ht29JszA4Qud8hZmYAev0UwuBgpC82GxCIN6iKerkYJjXkmmLpgFDJ7MpPyUSiAjRSG0OFUBGPtFqflpogzKbq4hzh66QLvj4V6N9w5CdqixGANLXn5eqgSDgmGKmWmKqXGymXmqgYmJUSqwGk9OTQPmNyOTFENDSxNJBhl8Jknhl5Zm4AJxwVu1TWQYWEqKSlNlgZVtSZIcOIwAhnR_cg
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_m_JhvOhU_phaU-lTc2rRlD0O2ftDZfVE62VtZmxSG0o61Iv73XuKme9pbuB9ckksul4-7C8CjSXHXoRqxgvhcIVrKlFg3UyVtxjThs0Bt83jn4cjwpuR1ps8q8LGJhRF5Qr9EckTUqAT1vRTr9fL_EssWvpXFc7xAUv7ihh1bXp-OxfmFyHav40zG9tiSLavjB_Io-MX4h5Rau7sH-ybPz8s3T289Hpey3DYq7gkcTJBfVp5C5T2vQ83a_L1Wh6Ph-sm7DofCRzMpkLjWw-IMnsK-o0rdrFwoooTiWcQ5_cYClaYFk3D0VyxPz-HBdULLU7Du6K-rkR9sN1S7gGqWZ-wSpBY1dKpriWGyJiEqQzOesBT1TSW01WqTK2js4nS9G76HmhcOB9GgP_Jv4JhDImybNKBarj7ZLRreMr4T8voBpMuCXw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TIE2+Anti-TIE2+antibody+and+Use+Thereof&rft.inventor=PARK+CHEONHO&rft.inventor=YOO+JIN+SAN&rft.inventor=PARK+BEOM+YONG&rft.inventor=LEE+WEON+SUP&rft.inventor=LEE+EUN+AH&rft.inventor=KANG+NU+RI&rft.inventor=LEE+YOUNGAE&rft.inventor=KIM+DO+YUN&rft.date=2021-02-24&rft.externalDBID=A&rft.externalDocID=KR20210020839A